AMAR REMEDIES | BAJAJ CONSUMER CARE | AMAR REMEDIES/ BAJAJ CONSUMER CARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -0.5 | 17.1 | - | View Chart |
P/BV | x | 0.1 | 6.8 | 0.9% | View Chart |
Dividend Yield | % | 0.0 | 6.5 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMAR REMEDIES Jun-12 |
BAJAJ CONSUMER CARE Mar-19 |
AMAR REMEDIES/ BAJAJ CONSUMER CARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 164 | 510 | 32.2% | |
Low | Rs | 86 | 308 | 27.9% | |
Sales per share (Unadj.) | Rs | 261.6 | 62.3 | 420.1% | |
Earnings per share (Unadj.) | Rs | 17.4 | 15.0 | 115.8% | |
Cash flow per share (Unadj.) | Rs | 22.3 | 15.5 | 143.7% | |
Dividends per share (Unadj.) | Rs | 0 | 14.00 | 0.0% | |
Dividend yield (eoy) | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 100.7 | 31.7 | 317.9% | |
Shares outstanding (eoy) | m | 26.16 | 147.50 | 17.7% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.5 | 6.6 | 7.3% | |
Avg P/E ratio | x | 7.2 | 27.2 | 26.4% | |
P/CF ratio (eoy) | x | 5.6 | 26.4 | 21.3% | |
Price / Book Value ratio | x | 1.2 | 12.9 | 9.6% | |
Dividend payout | % | 0 | 93.2 | 0.0% | |
Avg Mkt Cap | Rs m | 3,270 | 60,313 | 5.4% | |
No. of employees | `000 | NA | 1.3 | 0.0% | |
Total wages/salary | Rs m | 163 | 972 | 16.8% | |
Avg. sales/employee | Rs Th | NM | 7,289.5 | - | |
Avg. wages/employee | Rs Th | NM | 771.2 | - | |
Avg. net profit/employee | Rs Th | NM | 1,758.7 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,844 | 9,185 | 74.5% | |
Other income | Rs m | 21 | 170 | 12.3% | |
Total revenues | Rs m | 6,865 | 9,355 | 73.4% | |
Gross profit | Rs m | 1,131 | 2,744 | 41.2% | |
Depreciation | Rs m | 128 | 71 | 180.5% | |
Interest | Rs m | 398 | 12 | 3,401.7% | |
Profit before tax | Rs m | 626 | 2,832 | 22.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -50 | 0 | - | |
Tax | Rs m | 121 | 616 | 19.7% | |
Profit after tax | Rs m | 455 | 2,216 | 20.5% | |
Gross profit margin | % | 16.5 | 29.9 | 55.3% | |
Effective tax rate | % | 19.3 | 21.7 | 88.9% | |
Net profit margin | % | 6.6 | 24.1 | 27.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,904 | 4,250 | 115.4% | |
Current liabilities | Rs m | 3,581 | 1,376 | 260.2% | |
Net working cap to sales | % | 19.3 | 31.3 | 61.8% | |
Current ratio | x | 1.4 | 3.1 | 44.3% | |
Inventory Days | Days | 124 | 24 | 513.3% | |
Debtors Days | Days | 100 | 15 | 674.2% | |
Net fixed assets | Rs m | 1,689 | 1,769 | 95.5% | |
Share capital | Rs m | 262 | 148 | 177.6% | |
"Free" reserves | Rs m | 2,358 | 4,526 | 52.1% | |
Net worth | Rs m | 2,635 | 4,674 | 56.4% | |
Long term debt | Rs m | 507 | 0 | - | |
Total assets | Rs m | 6,862 | 6,052 | 113.4% | |
Interest coverage | x | 2.6 | 243.0 | 1.1% | |
Debt to equity ratio | x | 0.2 | 0 | - | |
Sales to assets ratio | x | 1.0 | 1.5 | 65.7% | |
Return on assets | % | 12.4 | 36.8 | 33.8% | |
Return on equity | % | 17.3 | 47.4 | 36.4% | |
Return on capital | % | 31.0 | 60.8 | 51.0% | |
Exports to sales | % | 4.0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 273 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 273 | 123 | 221.9% | |
Fx outflow | Rs m | 2 | 26 | 7.8% | |
Net fx | Rs m | 271 | 97 | 278.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -313 | 1,764 | -17.7% | |
From Investments | Rs m | -489 | 686 | -71.3% | |
From Financial Activity | Rs m | 769 | -2,384 | -32.2% | |
Net Cashflow | Rs m | -33 | 62 | -52.5% |
Indian Promoters | % | 25.5 | 66.9 | 38.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 9.2 | 1.6 | 564.4% | |
FIIs | % | 0.0 | 24.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 65.3 | 7.1 | 919.7% | |
Shareholders | 13,061 | 19,219 | 68.0% | ||
Pledged promoter(s) holding | % | 99.7 | 0.0 | - |
Compare AMAR REMEDIES With: P&G HYGIENE LINC PEN & PLASTICS KARUTURI GLOBAL COLGATE EMAMI
Compare AMAR REMEDIES With: P&G (US) UNILEVER PLC. (UK) HYPERMARCAS (Brazil)
Asian stock markets are trading on a strong note today. The Hang Seng is trading up by 2% while the Shanghai Composite is up 0.6%. The Nikkei is trading higher by 0.4%.
For the quarter ended September 2020, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (down 0.1% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
For the quarter ended December 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 501 m (down 16.7% YoY). Sales on the other hand came in at Rs 2 bn (down 7.9% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
For the quarter ended September 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 573 m (up 10.9% YoY). Sales on the other hand came in at Rs 2 bn (up 2.1% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
For the quarter ended June 2019, BAJAJ CONSUMER CARE has posted a net profit of Rs 587 m (up 9.1% YoY). Sales on the other hand came in at Rs 2 bn (up 8.5% YoY). Read on for a complete analysis of BAJAJ CONSUMER CARE's quarterly results.
Here's an analysis of the annual report of BAJAJ CONSUMER CARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BAJAJ CONSUMER CARE. Also includes updates on the valuation of BAJAJ CONSUMER CARE.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.
Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.
More